Results 201 to 208 of about 61,878 (208)

Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)

Lancet, The, 2017
Krishnansu S Tewari, Ana Oaknin, Michael J Birrer   +2 more
exaly  

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

Journal of Clinical Oncology, 2019
Krishnansu S Tewari, Danielle M Enserro, Barbara M Norquist   +2 more
exaly  

Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial

Lancet Oncology, The, 2017
Véronique Diéras, Ian E Krop, Luca Gianni   +2 more
exaly  

Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non–Small-Cell Lung Cancer

Journal of Clinical Oncology, 2018
Benjamin J Solomon, Dong-Wan Kim, Yi-Long Wu   +2 more
exaly  

Breast Cancer Screening: A Final Analysis?

Ca-A Cancer Journal for Clinicians, 2003
exaly  

La Codina, un caso tardío de inhumación en el Bronce Final

2007
Carrascal, Susana, Armentano, Núria, Rissech, Carme, Malet, Anna Camats, Cardona, Ramon, Rodríguez, Pablo Martínez   +5 more
openaire   +1 more source

Las estelas diademadas, representaciones de jefaturas femeninas en el Bronce Final

2012
openaire   +1 more source

Branching ratios and spectral functions of τ decays: Final ALEPH measurements and physics implications

Physics Reports, 2005
exaly